W. Dornoff

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Jean‐Jacques Body, Ingo Diel, E.D. Kreuser et al. · Annals of Oncology · 2003 · 414 citations · Full text

Bone Disease, Bone Health, Skeletal Complications +11

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 169 citations

Engineering, Oncologic Imaging, Medical Imaging +9

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

Ingo Diel, Jean‐Jacques Body, E.D. Kreuser et al. · European Journal of Cancer · 2004 · 164 citations

Bone Disease, Bone Health, Oncology +9

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

C. Manegold, Bengt Bergman, A. Chemaissani et al. · Annals of Oncology · 1997 · 114 citations · Full text

Medicine, Single-agent Gemcitabine, Metronomic Therapy +7

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Bengt Bergman, Assad Chemaissani, W. Dornoff et al. · Lung Cancer · 1999 · 72 citations

Oncology, Cisplatin-based Chemotherapy, Medicine +6